Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing ...

Dr Adam Friedman discusses the clinical impact of CSU updates, highlighting emerging therapies, dietary insights, and patient ...

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Strategic ...

The following is a summary of “Patient and physician perspectives on disease burden in chronic spontaneous urticaria,” ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

When your skin is red, itchy, and irritated, it could be a rash or it might be hives. We spoke with experts to learn how to ...

Remibrutinib results in significant improvement in composite measure of itching and hives after second-generation H1-antihistamine treatment.